| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research [V. P. T., G. R. M.], and Laboratory of Pathophysiology, National Cancer Institute, [L. A. L., R. G. R.], NIH, Bethesda, Maryland 20205
We have studied the attachment of two murine metastatic cell lines and of a transformed, nonmetastatic sarcoma cell line to type IV (basement membrane) collagen. The metastatic cells attached preferentially to type IV collagen, whereas the nonmetastatic cells attached best to type I collagen. Laminin increased both the rate and the number of metastatic cells attaching to type IV collagen, while fibronectin had no effect. Antibodies to laminin prevented the attachment of metastatic cells to type IV collagen, while antibodies to fibronectin prevented the attachment of the nonmetastatic cells. The number of pulmonary metastases which formed after i.v. injection of cells into C57BL mice was used to measure the metastatic propensity of these cell lines. A subpopulation of the metastatic cells selected for by their ability to attach to type IV collagen in the presence of laminin produced more metastases than did unattached cells or cells attached with fibronectin. In addition, incubation of metastatic cells with antibody to laminin prior to injection into mice markedly reduced the number of lung metastases. These data suggest that laminin promotes the attachment of metastatic tumor cells to basement membrane during the metastatic process.
Received 11/18/81. Accepted 3/10/82.
This article has been cited by other articles:
![]() |
A. Uemura, M. Nakamura, S. Kachi, Y. Nishizawa, T. Asami, Y. Miyake, and H. Terasaki Effect of Plasmin on Laminin and Fibronectin During Plasmin-Assisted Vitrectomy Arch Ophthalmol, February 1, 2005; 123(2): 209 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Engbring, M. P. Hoffman, A. J. Karmand, and H. K. Kleinman The B16F10 Cell Receptor for a Metastasis-promoting Site on Laminin-1 Is a Heparan Sulfate/Chondroitin Sulfate-containing Proteoglycan Cancer Res., June 1, 2002; 62(12): 3549 - 3554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Freire and T. Coelho-Sampaio Self-assembly of Laminin Induced by Acidic pH J. Biol. Chem., January 14, 2000; 275(2): 817 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Nemer, P. Gane, Y. Colin, V. Bony, C. Rahuel, F. Galacteros, J. P. Cartron, and C. L. Van Kim The Lutheran Blood Group Glycoproteins, the Erythroid Receptors for Laminin, Are Adhesion Molecules J. Biol. Chem., July 3, 1998; 273(27): 16686 - 16693. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chan, N Matsuura, Y Takada, B. Zetter, and M. Hemler In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells Science, March 29, 1991; 251(5001): 1600 - 1602. [Abstract] [PDF] |
||||
![]() |
V.P. Terranova, M. Jendresen, and F. Young Healing, Regeneration, and Repair: Prospectus for New Dental Treatment Advances in Dental Research, May 1, 1989; 3(1): 69 - 79. [Abstract] [PDF] |
||||
![]() |
K. Gehlsen, L Dillner, E Engvall, and E Ruoslahti The human laminin receptor is a member of the integrin family of cell adhesion receptors Science, September 2, 1988; 241(4870): 1228 - 1229. [Abstract] [PDF] |
||||
![]() |
Y Iwamoto, F. Robey, J Graf, M Sasaki, H. Kleinman, Y Yamada, and G. Martin YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation Science, November 20, 1987; 238(4830): 1132 - 1134. [Abstract] [PDF] |
||||
![]() |
J. Lopes, M dos Reis, and R. Brentani Presence of laminin receptors in Staphylococcus aureus Science, July 19, 1985; 229(4710): 275 - 277. [Abstract] [PDF] |
||||
![]() |
V. Terranova, J. Williams, L. Liotta, and G. Martin Modulation of the metastatic activity of melanoma cells by laminin and fibronectin Science, November 23, 1984; 226(4677): 982 - 985. [Abstract] [PDF] |
||||
![]() |
W. El Nemer, P. Gane, Y. Colin, A. M. D'Ambrosio, I. Callebaut, J.-P. Cartron, and C. L. Van Kim Characterization of the Laminin Binding Domains of the Lutheran Blood Group Glycoprotein J. Biol. Chem., June 22, 2001; 276(26): 23757 - 23762. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |